Sanara MedTech (SMTI) Receivables (2010 - 2026)

Sanara MedTech's Receivables history runs 17 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• Quarterly Receivables rose 31702.25% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 31702.25% YoY) and the FY2025 annual result came in at $12.0 million, down 11.19% from the prior year.
• Receivables was $13.6 million for Q1 2026 at Sanara MedTech, up from $12.0 million in the prior quarter.
• Across five years, Receivables topped out at $13.6 million in Q1 2026 and bottomed at $20662.0 in Q2 2023.
• A 5-year average of $7.0 million and a median of $7.4 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables sank 99.49% — and 2024, when it soared 50697.32%.
• Sanara MedTech's Receivables stood at $6.9 million in 2022, then advanced by 22.75% to $8.5 million in 2023, then surged by 59.41% to $13.5 million in 2024, then fell by 11.19% to $12.0 million in 2025, then grew by 13.5% to $13.6 million in 2026.
• Business Quant data shows SMTI's Receivables at $13.6 million in Q1 2026, $12.0 million in Q4 2025, and $12.1 million in Q3 2025.